| 1F0J | B:152-488; A:152-508 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B2B |
| 1MKD | A:183-510; B:183-510; C:183-510; D:183-510; E:183-510; F:183-510; G:183-510; H:183-510; I:183-510; J:183-510; K:183-510; L:183-510 | CRYSTAL STRUCTURE OF PDE4D CATALYTIC DOMAIN AND ZARDAVERINE COMPLEX |
| 1OYN | B:86-412; C:86-412; A:79-412; D:79-412 | CRYSTAL STRUCTURE OF PDE4D2 IN COMPLEX WITH (R,S)-ROLIPRAM |
| 1PTW | B:86-412; C:86-412; A:79-412; D:79-412 | THE CRYSTAL STRUCTURE OF AMP-BOUND PDE4 SUGGESTS A MECHANISM FOR PHOSPHODIESTERASE CATALYSIS |
| 1Q9M | B:86-412; C:84-412; A:79-412; D:79-412 | THREE DIMENSIONAL STRUCTURES OF PDE4D IN COMPLEX WITH ROLIPRAMS AND IMPLICATION ON INHIBITOR SELECTIVITY |
| 1RKP | A:535-860 | CRYSTAL STRUCTURE OF PDE5A1-IBMX |
| 1RO6 | A:152-495; B:152-495 | CRYSTAL STRUCTURE OF PDE4B2B COMPLEXED WITH ROLIPRAM (R & S) |
| 1RO9 | B:152-488; A:152-489 | CRYSTAL STRUCTURES OF THE CATALYTIC DOMAIN OF PHOSPHODIESTERASE 4B2B COMPLEXED WITH 8-BR-AMP |
| 1ROR | B:152-488; A:152-489 | CRYSTAL STRUCTURES OF THE CATALYTIC DOMAIN OF PHOSPHODIESTERASE 4B2B COMPLEXED WITH AMP |
| 1T9R | A:534-862 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 5A |
| 1T9S | A:534-858; B:534-858 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 5A IN COMPLEX WITH GMP |
| 1TAZ | A:146-502 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 1B |
| 1TB5 | A:163-485; B:163-485 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH AMP |
| 1TB7 | B:86-411; A:87-411 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH AMP |
| 1TBB | B:87-412; A:88-411 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH ROLIPRAM |
| 1TBF | A:534-858 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 5A IN COMPLEX WITH SILDENAFIL |
| 1UDT | A:537-860 | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 5 COMPLEXED WITH SILDENAFIL(VIAGRA) |
| 1UDU | A:537-860; B:537-860 | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 5 COMPLEXED WITH TADALAFIL(CIALIS) |
| 1UHO | A:537-860 | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 5 COMPLEXED WITH VARDENAFIL(LEVITRA) |
| 1XLX | A:163-485; B:163-485 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH CILOMILAST |
| 1XLZ | A:163-485; B:163-485 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH FILAMINAST |
| 1XM4 | A:163-485; B:163-485 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH PICLAMILAST |
| 1XM6 | B:163-511; A:163-513 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH (R)-MESOPRAM |
| 1XMU | A:155-485; B:163-485 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH ROFLUMILAST |
| 1XMY | A:163-485; B:163-485 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH (R)-ROLIPRAM |
| 1XN0 | A:163-485; B:163-485 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH (R,S)-ROLIPRAM |
| 1XOM | A:86-411; B:88-411 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH CILOMILAST |
| 1XON | B:86-411; A:86-411 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH PICLAMILAST |
| 1XOQ | A:86-411; B:86-411 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH ROFLUMILAST |
| 1XOR | B:86-412; A:88-411 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH ZARDAVERINE |
| 1XOS | A:162-485 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH SILDENAFIL |
| 1XOT | A:163-485; B:163-485 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH VARDENAFIL |
| 1XOZ | A:534-858 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 5A IN COMPLEX WITH TADALAFIL |
| 1XP0 | A:534-858 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 5A IN COMPLEX WITH VARDENAFIL |
| 1Y2B | A:86-411; B:86-411 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH 3,5-DIMETHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER |
| 1Y2C | A:86-411; B:86-411 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH 3,5-DIMETHYL-1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER |
| 1Y2D | A:86-411; B:86-411 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH 1-(4-METHOXY-PHENYL)-3,5-DIMETHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER |
| 1Y2E | A:86-411; B:88-411 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH 1-(4-AMINO-PHENYL)-3,5-DIMETHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER |
| 1Y2H | A:163-485; B:163-485 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH 1-(2-CHLORO-PHENYL)-3,5-DIMETHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER |
| 1Y2J | A:163-485; B:163-485 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH 3,5-DIMETHYL-1-(3-NITRO-PHENYL)-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER |
| 1Y2K | A:86-411; B:86-411 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH 3,5-DIMETHYL-1-(3-NITRO-PHENYL)-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER |
| 1ZKN | B:86-412; C:83-412; A:79-412; D:79-412 | STRUCTURE OF PDE4D2-IBMX |
| 2CHM | A:537-858 | CRYSTAL STRUCTURE OF N2 SUBSTITUTED PYRAZOLO PYRIMIDINONES-A FLIPPED BINDING MODE IN PDE5 |
| 2FM0 | B:86-412; C:86-412; A:79-412; D:79-412 | CRYSTAL STRUCTURE OF PDE4D IN COMPLEX WITH L-869298 |
| 2FM5 | B:86-412; C:86-412; A:79-412; D:79-412 | CRYSTAL STRUCTURE OF PDE4D2 IN COMPLEX WITH INHIBITOR L-869299 |
| 2H40 | A:535-860 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF UNLIGANDED PDE5 |
| 2H42 | A:535-860; B:535-860; C:535-860 | CRYSTAL STRUCTURE OF PDE5 IN COMPLEX WITH SILDENAFIL |
| 2H44 | A:535-860 | CRYSTAL STRUCTURE OF PDE5A1 IN COMPLEX WITH ICARISID II |
| 2HD1 | A:181-506; B:181-506 | CRYSTAL STRUCTURE OF PDE9 IN COMPLEX WITH IBMX |
| 2PW3 | B:88-412; A:86-412 | STRUCTURE OF THE PDE4D-CAMP COMPLEX |
| 2YY2 | A:181-506; B:181-504 | CRYSTAL STRUCTURE OF THE HUMAN PHOSPHODIESTERASE 9A CATALYTIC DOMAIN COMPLEXED WITH IBMX |
| 3B2R | A:531-860; B:538-860 | CRYSTAL STRUCTURE OF PDE5A1 CATALYTIC DOMAIN IN COMPLEX WITH VARDENAFIL |
| 3BJC | A:535-860 | CRYSTAL STRUCTURE OF THE PDE5A CATALYTIC DOMAIN IN COMPLEX WITH A NOVEL INHIBITOR |
| 3DY8 | A:178-505; B:178-505 | HUMAN PHOSPHODIESTERASE 9 IN COMPLEX WITH PRODUCT 5'-GMP (E+P COMPLEX) |
| 3DYL | A:178-505; B:178-505 | HUMAN PHOSPHDIESTERASE 9 SUBSTRATE COMPLEX (ES COMPLEX) |
| 3DYN | A:178-505; B:178-505 | HUMAN PHOSPHODIESTRASE 9 IN COMPLEX WITH CGMP (ZN INHIBITED) |
| 3DYQ | A:178-505; B:178-505 | HUMAN PHOSPHODIESTRASE 9 (INHIBITED BY OMITTING DIVALENT CATION) IN COMPLEX WITH CGMP |
| 3DYS | A:182-505; B:178-505 | HUMAN PHOSPHODIESTRASE-5'GMP COMPLEX (EP), PRODUCED BY SOAKING WITH 20MM CGMP+20 MM MNCL2+20 MM MGCL2 FOR 2 HOURS, AND FLASH-COOLED TO LIQUID NITROGEN TEMPERATURE WHEN SUBSTRATE WAS STILL ABUDANT. |
| 3HC8 | A:536-858 | INVESTIGATION OF AMINOPYRIDIOPYRAZINONES AS PDE5 INHIBITORS: EVALUATION OF MODIFICATIONS TO THE CENTRAL RING SYSTEM. |
| 3JSI | A:178-505; B:178-505 | HUMAN PHOSPHODIESTERASE 9 IN COMPLEX WITH INHIBITOR |
| 3JSW | A:178-505; B:178-505 | HUMAN PDE9 IN COMPLEX WITH SELECTIVE INHIBITOR |
| 3JWQ | C:533-859; A:536-859; B:536-859; D:537-859 | CRYSTAL STRUCTURE OF CHIMERIC PDE5/PDE6 CATALYTIC DOMAIN COMPLEXED WITH SILDENAFIL |
| 3K3E | A:187-506; B:187-506 | CRYSTAL STRUCTURE OF THE PDE9A CATALYTIC DOMAIN IN COMPLEX WITH (R)-BAY73-6691 |
| 3K3H | A:186-506; B:186-506 | CRYSTAL STRUCTURE OF THE PDE9A CATALYTIC DOMAIN IN COMPLEX WITH (S)-BAY73-6691 |
)
)